The Sixth Annual

EAO-CRC

Early Age Onset
Colorectal Cancer Summit

New York City

April 22-23, 2020

EAOCRC 2020 Host Logos

Putting Knowledge Into Action

Join us at the Sixth Annual EAO CRC Summit for a full day of cutting edge medical and research advances, community building, conversation and action focused on addressing young adult-onset colorectal cancer, featuring an international medical and scientific faculty of experts.

DETAILED SCHEDULE AND FACULTY INFORMATION COMING SOON

2019 COURSE SCHEDULE

Thursday, May 2, 2019 – 7:00 AM – 8:00 AM Registration and Breakfast
Thursday, May 2, 2019 – 8:00 AM – 8:30 AM Framing the Conversation: Strategic Challenges in Current Medical Care that Contribute to Young Adult Colorectal Cancer (CRC) Incidence and Mortality.
Thursday, May 2 – 8:30 AM – 9:35 AM SESSION I: The Dimensions of the EAO-CRC Problem: Target Item: Accurate, Regular, Up To Date Measurement of Key Metrics Describing the Early Age Onset Colorectal Cancer Public Health Crisis.
Thursday, May 2 – 9:50 AM – 11:35 AM SESSION II: Family History Ascertainment In The U.S. (Addressing Gap 1) What Steps are Needed to Improve the Well Documented Less Than Optimal Status of This Situation? What is Our Best Information on the Documentation of Cancer Family History in Primary Care? What are the Key Elements Required for Success?
Thursday, May 2 – 12:15 PM – 1:20 PM
SESSION III: Earliest Possible Diagnosis and Treatment Through Timely Recognition of the Symptoms and Signs of Young Adult CRC (Addressing Gap 2)
Thursday, May 2 – 1:20 PM – 3:00 PM SESSION IV: Timely, Effective, Quality Of Life and Fertility Preserving State of the Art Treatment (Addressing Gap 3)
Thursday, May 2 – 3:00 PM – 5:35 PM SESSION V: How Did This Happen? Investigating the Causes of Early Onset Colorectal Cancers (EAO-CRC) (Addressing Gap 4)
Friday, May 3 – 9:05 AM – 10:05 AM SESSION VI: Palliative Care: Why Early Is Best. (Including guidance, support and resources to patients and caregivers during their treatment journey/continuum of care. (Addressing Gap 5)
Friday, May 3 – 10:05 AM – 10:25 AM SESSION VII: Epigenetics and Its Future Role in the Diagnosis and Treatment of Individuals More Specifically and Accurately
Friday May 3 – 10:45 AM – 11:20 PM SESSION VIII: Strategic Planning Session (Breakout sessions according to GAP)
Friday May 3 – 11:20 AM – 11:45 AM SESSION IX: Report back from strategic action planning breakout groups
Friday, May 3 – 11:45 AM – 12:15 PM Closing Remarks Including Poster Session Award Presentations

COURSE PLANNING COMMITTEE

Thomas K. Weber, MD, FACS

COURSE MODERATOR/CHAIR

Director Of Surgical Oncology
Northwest Region at Northwell Health
Professor of Surgery Zucker School of Medicine at Hofstra/Northwell
Founder and President
Colon Cancer Foundation

Andrew Albert, MD

Planning Committee Member

Chicago Gastro, LLC

Cindy R. Borassi

Planning Committee Member

Executive Director, Colon Cancer Foundation

Jennifer Butler

Planning Committee Member

Member, Board of Directors
Colon Cancer Foundation

Cathy Eng, MD, FACP, FASCO

Planning Committee Member

Vanderbilt-Ingram Cancer Center
David H. Johnson Chair in Surgical and Medical Oncology
Vice-Chair, SWOG GI Committee
Institutional PI, SWOG
Professor of Medicine, Hematology and Oncology
Co-Director, GI Oncology
Co-Leader, Gastrointestinal Cancer Research Program

Heather Hampel, MS, LGC

Planning Committee Member

Associate Director, Division of Human Genetics
Associate Director, Biospecimen Research
Professor, Internal Medicine
Licensed Genetic Counselor
The Ohio State University Comprehensive Cancer Center

Krista Nelson, LCSW OSW-C BCD FAOSW

Planning Committee Member

Oncology Social Worker
Program Manager, Quality & Research, Cancer Support Services & Compassion
Providence Cancer Institute & Providence St Joseph Health

Erin Peterson

Planning Committee Member

Communications Director
Colon Cancer Coalition

Susan K. Peterson, PhD, MPH

Planning Committee Member and Poster Session Chair

Professor of Behavioral Science
The University of Texas MD Anderson Cancer Center

Mary B. Strong, MA

Planning Committee Member

Assistant Vice President, Continuing Medicial Education, Northwell Health

Ronit Yarden, Ph.D. MHSA

Planning Committee Member

Senior Director of Medical Affairs
Colorectal Cancer Alliance

Yi-Qian Nancy You, MD, MHSc, FACS

Planning Committee Member

Department of Surgical Oncology, Division of Surgery

Yi-Qian Nancy You, MD, MHSc, FACS

Planning Committee Member

Department of Surgical Oncology, Division of Surgery

COURSE OBJECTIVES

This event will bring together leading clinicians, scientists as well as early age onset (EAO) colorectal cancer (CRC) survivors and Caregivers from across the country and internationally . The program will provide extensive opportunities for participants to advance their understanding of the rapidly increasing incidence of rectal and colon cancer among young adults under 50 years of age in the U.S. and abroad.

This groundbreaking program will, for a sixth consecutive year, provide all participants the opportunity to hear and question leading clinicians and researchers on the life saving potential of timely clinical risk assessment / family cancer health history; earliest possible stage, optimal, fertility preserving clinical care, as well as the latest information regarding national and international EAO CRC incidence trends, pathogenesis, and genetics. In addition, this year’s program will present a “Research in Progress” segment featuring currently NCI funded and planned EAO CRC research  projects from across America and Europe. Again this year, important Break-Out Sessions based on needs-assessments from our survivor community will address challenging issues surrounding Palliative Care, support networks for “Caregivers” and a “Primer” on the “Epigenetics” of EAO CRC specifically requested by our Young Adult CRC Survivor Program Advisory Group.

The course will include lectures, workshops and panel discussions designed to advance the “state-of-the-science” addressing EAO-CRC. Our faculty will once again be world class speakers representing leading academic medical centers with major additional inspiring programmatic contributions from the Early Age Onset Colorectal Cancer Survivor Community of the United States and beyond.

EDUCATIONAL OBJECTIVES

  • Provide an expert review of the latest published information on the increasing incidence and mortality associated with Early Age Onset Colorectal Cancer in the United States and globally.
  • Review the State-of-the-Science regarding the known and possible causes of the increasing incidence of EAO-CRC including alterations in our food and water supply, the contribution of novel germline genetic factors and etiologic clues based on the molecular biology of EAO-CRC cancers.
  • Provide an evidence-based framework for reducing risk, increasing early stage diagnosis and improving treatment and outcomes for young adult colorectal cancer patients.
  • Define the “Gaps” in our current understanding of Early Age Onset Colorectal Cancer in order to set our clinical and research priorities and develop a strategic plan to reduce EAO-CRC incidence and mortality.

PLANNED PRESENTATIONS AND INVITED FACULTY INCLUDE

CRC 2019 BROCHURE

THURSDAY, MAY 2, 2019

7:00 AM – 8:00 AM REGISTRATION AND BREAKFAST

8:00 AM – 8:30 AM FRAMING THE CONVERSATION: STRATEGIC CHALLENGES IN CURRENT MEDICAL CARE THAT CONTRIBUTE TO YOUNG ADULT COLORECTAL CANCER (CRC) INCIDENCE AND MORTALITY. SURVIVOR TESTIMONIALS UNDERSCORE OPPORTUNITIES FOR IMPROVEMENT IN THE PREVENTION AND CARE OF YOUNG ADULT COLORECTAL CANCER.

  • Chelsea Boet,Sarah Debord, Kevin Hays, Kim Newcomer, Susan Pfau, Eric Reddy, Valarie Schlosser, Diana Sloan, Denelle Suranski, Tabitha Trent, Wes Hensel
  • Opening Remarks: Richard R. Barakat, MD, Physician-in-Chief and Director, Northwell Health Cancer Institute
  • How the Survivor Testimonials Framed Today’s Program: Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation
  • Housekeeping: Cindy R. Borassi, Colon Cancer Foundation  

8:30 AM – 9:35 AM SESSION I: THE DIMENSIONS OF THE EAO-CRC PROBLEM: TARGET ITEM: ACCURATE, REGULAR, UP TO DATE MEASUREMENT OF KEY METRICS DESCRIBING THE EARLY AGE ONSET COLORECTAL CANCER PUBLIC HEALTH CRISIS.

8:30 AM – 8:40 AM

  • Overview of Global EAO-CRC Incidence Patterns and Trends
    • Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation

8:40 AM – 8:50 AM

  • Overview of United States EAO-CRC Incidence Patterns and  Trends
    • Rebecca L. Siegel, MPH, American Cancer Society

8:50 AM – 9:00 AM

  • Utilization of Detailed Centers  for Disease Control (CDC) Cancer Registry Data in the Age of Genomic Medicine
    • Jordan Karlitz, MD, FACG Tulane University School of Medicine  (VIA VIDEO CONFERENCING)

9:00 AM – 9:10 AM

  • Overview of European Cancer Registries Data Resources on EAO-CRC
    • Irit Ben-Aharon, MD, PhD, Rambam Health Care Campus, Haifa, Israel, European Organisation for Research and Treatment of Cancer (EORTC)

9:10 AM – 9:20 AM

  • Survey of Young Onset Patients, Survivors, and Caregivers: Self-Reported Clinical, Psychosocial, Financial and Quality of Life Experiences.
    • Ronit Yarden, Ph.D. MHSA, Colorectal Cancer Alliance

9:20 AM – 9:35 AM

  • Q&A Panel Discussion – Strategic Plan Development

9:35 AM – 9:50 AM

  • Networking, Coffee, Poster Viewing Break

9:50 AM – 11:35 AM  SESSION II: FAMILY HISTORY ASCERTAINMENT IN THE U.S. (ADDRESSING  GAP 1) WHAT STEPS ARE NEEDED TO IMPROVE THE WELL DOCUMENTED LESS THAN OPTIMAL STATUS OF THIS SITUATION? WHAT IS OUR BEST INFORMATION ON THE DOCUMENTATION OF CANCER FAMILY HISTORY IN PRIMARY CARE?  WHAT ARE THE KEY ELEMENTS REQUIRED FOR SUCCESS.

Moderator:  Gregory Feero, MD, PhD, Maine Dartmouth Family Medicine Residency, Augusta, ME; Geisel School of Medicine at Dartmouth, Hanover, NH

9:50 AM – 10:10 AM

  • Electronic Health Records (EHR) and family cancer history ascertainment. The path forward?   
    • Gregory Feero, MD, PhD, Maine Dartmouth Family Medicine Residency, Augusta, ME; Geisel School of Medicine at Dartmouth, Hanover, NH

10:10 AM – 10:25 AM

  • Review of National Colorectal Cancer Roundtable (NCCRT) Family Health History Early Age Onset Colorectal Cancer (EAO-CRC) Task Group Progress  and Overview of the NCCRT Risk Assessment and Screening Toolkit to Detect Familial, Hereditary and Early Onset Colorectal Cancer and next steps for dissemination and implementation
    • Dennis Ahnen, MD, AGAF, FACG, University of Colorado School of Medicine, Gastroenterology of the Rockies

10:25 AM – 10:40 AM

  • Implementation plan for 2018 American Cancer Society recommendations (and rationale) for screening for the early detection of colorectal cancer.
    • Robert A. Smith, PhD, American Cancer Society

10:40 AM – 10:50 AM

  • Strategies for Addressing Early Onset CRC: An NCCRT Report
    • Jan Lowery, Colorado Center for Personalized Medicine

10:50 AM – 11:00 AM

  • Detecting Unaffected Individuals with Lynch Syndrome (DUAL).  
    • Sayoni Lahiri, MS, CGC, UT Southwestern Medical Center

11:00 AM – 11:10 AM

  • Prevalence of Advanced Colorectal Polyps Among First Degree Relatives of EOCRC patients
    • Christine L. Sardo Molmenti, PhD, MPH Feinstein Institute for Medical Research, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

11:10 AM – 11:15 AM  

  • Integrating education on the importance of family health history ascertainment and earliest possible diagnosis into the entire continuum of medical and specialty education from medical school through Board Certification, CME and Recertification.
    • Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation

11:15 AM – 11:30 AM

  • Q&A Panel Discussion – Strategic Plan Development

11:30 AM – 12:15 PM

LUNCH

12:15 PM – 1:20 PM SESSION III: EARLIEST POSSIBLE DIAGNOSIS AND TREATMENT THROUGH TIMELY RECOGNITION OF THE SYMPTOMS AND SIGNS OF YOUNG ADULT CRC (ADDRESSING GAP 2)

Moderator: Whitney Jones, MD, Clinical Professor of Medicine, University of Louisville

12:15 PM – 12:25 PM

  • A review of the published data documenting delays in diagnosis and the consequences in terms of later stage diagnosis and poorer outcomes
    • Whitney F. Jones, MD, Gastro & Endo Associate

12:25 PM – 12:35 PM

  • Overview of the continuum of providers who interact with patients prior to and up to a diagnosis
    • Chelsea Boet, MD, Spectrum Health Medical Group

12:35 PM – 12:45 PM

  • Lessons Learned: What have we learned from past public health success stories?  
    • Jennifer Brown, PhD, NYC Department of Health & Mental Hygiene

12:45 PM – 12:55 PM

  • Lessons Learned: What have we learned from past public health success stories?  
    • Tony Foleno, Senior Vice President, Strategy & Evaluation, Ad Council; President, Society for Health Communication

12:55 PM – 1:05 PM

  • Introduction of the EAO-CRC National Clinical Alert and Symptoms and Signs Index
    • Andrew Albert, MD, MPH, Chicago Gastro LLC.
    • Erin Peterson, Colon Cancer Coalition
      • Provider Education Outreach Initiatives
      • Patient Awareness and Advocacy Initiatives

1:05 PM – 1:20 PM

  • Q&A Panel Discussion – Strategic Plan Development

1:20 PM – 2:45 PM SESSION IV: TIMELY, EFFECTIVE, QUALITY OF LIFE & FERTILITY PRESERVING STATE OF THE ART TREATMENT (ADDRESSING GAP 3)  

1:20 PM – 1:30 PM

  • Updates on Current Medical Oncology Approaches to Young-Onset CRC
    • Andrea Cercek, MD, Memorial Sloan Kettering Cancer Center

1:30 PM – 1:40 PM

  • Optimal Preservation of Fertility  
    • Nicole Noyes MD, Reproductive Endocrinologist, Northwell Health

1:40 PM – 1:50 PM

  • Novel Approaches to Metastatic Mismatch Repair (MMR) deficient and Microsatellite Stable (MSS) metastatic Colorectal Cancer
    • Cathy Eng, MD, FACP, FASCO, The University of Texas MD Anderson Cancer Center

1:50 PM – 2:00 PM

  • From “Bench to Bedside” CRC Experimental Therapeutics and Phase I & II Trials. What’s New & What’s Next?
    • Wasif M. Saif, MD, MBBS Northwell Health Cancer Institute

2:00 PM – 2:10 PM

  • GAPS in providing Palliative Care and the cost benefit ratio for hospital systems
    • James T. D’Olimpio, MD, FACP, FAAHPM North Shore University Hospital

2:10 PM -2:20 PM

  • Q&A Panel Discussion

2:20 PM – 2:35 PM

  • Identifying the Key Elements of a Center for Early Age Onset Colorectal Cancer – Panel Discussion
    • Eric Reddy, Stage IV Colorectal Cancer Survivor
    • Andrea Cercek, MD, Memorial Sloan Kettering Cancer Center
    • Zana Correa, NP, Memorial Sloan Kettering Cancer Center
    • Kimmie NG, MD, MPH, Dana-Farber Cancer Institute
    • Karen Fasciano, PsyD, Dana-Farber Cancer Institute
    • Christine Louise S. Molmenti, MPH, PhD Feinstein Institute for Medical Research/ Northwell Health
    • Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation
    • Krista Nelson, LCSW OSW-C BCD FAOSW, Providence Cancer Institute, Providence St Joseph Health

2:35 PM – 2:45 PM

  • Q&A Panel Discussion – Strategic Plan Development

2:45 PM – 3:00 PM

  • Networking, Coffee, Poster Viewing Break

3:00 PM – 5:35 PM SESSION V: HOW DID THIS HAPPEN? INVESTIGATING THE CAUSES OF EARLY ONSET COLORECTAL CANCERS (EAO-CRC) (ADDRESSING GAP 4)

The Genetics of Heritable CRC: What’s New and Important to Know Regarding the Genetics of EAO-CRC? Moderators: Professors Kauff & Weber

Moderator(s): Noah D. Kauff, MD, Duke Cancer Institute, Duke University Health System and Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation

3:00 PM – 3:10 PM

  • Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients with Early-Onset Colorectal Cancer.
    • Heather Hampel, MS, LGC, The Ohio State University Comprehensive Cancer Center

3:10 PM – 3:20 PM

  • Molecular subtype of colorectal cancer associated with early age of onset
    • Xavier Llor, MD, PhD, Yale University School of Medicine Smilow Cancer Center

3:20 PM – 3:30 PM

  • Germline Genetic Variants Associated with Young-Onset Colorectal Cancer: The MSKCC Experience   
    • Zsofia K. Stadler, MD Clinical Director, Clinical Genetics Service, Memorial Sloan Kettering Cancer Center

3:30 PM – 3:40 PM

  • Germline Genetic Features of Young Individuals with Colorectal Cancer
    • Elena M. Stoffel MD MPH, Director Cancer Genetics Clinic, University of Michigan

3:40 PM – 3:50 PM

  • Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
    • Matthew B. Yurgelun MD, Dana-Farber Cancer Institute, Harvard Medical School

What is driving the increases in EAO-CRC,  80 + % of which is NOT related to the Named Hereditary CRC Syndromes ?   

3:50 PM – 4:00 PM

  • Obesity, Sedentary Behaviors, and Early-Onset CRC,  Yin Cao, MPH, ScD, MPH, Washington University School of Medicine

4:00 PM – 4:10 PM

  • New Suspects: Diet, Microbiome, Immunology and Cancer Risk, Semir Beyaz, PhD, Cold Spring Harbor Laboratories

4:10 PM – 4:20 PM

  • New Research Information: Current Efforts to investigate the causes of increases in MSS CRC among young adults.
    • The United States:
      • Current NCI Funded Investigations into the Causes of Early Age Onset Colorectal Cancer:
          • Colorectal Cancer Risks in People < 50 Years of Age  NIH (RO3): Epidemiology, Richard Hayes, DDS, PhD, MPH, The Cancer Institute at NYU Langone

4:20 PM – 4:30 PM

  • Presentation Early Life Risk Factors and Risk of Colorectal Neoplasia, Kana Wu, MD, PhD, Harvard T.H. Chan School of Public Health, Dana-Farber, Harvard Cancer Center

4:30 PM – 4:40 PM

  • The European Union: Funded Investigations 
    • European Organization for Research and Treatment of Cancer (EORTC): Young Onset CRC: Causation, Treatment and Outcomes, Irit Ben-Aharon, MD, PhD, Rambam Health Care Campus, Haifa, Israel European Organisation for Research and Treatment of Cancer

4:40 PM – 4:50 PM

  • European study of Early-onset Colorectal Cancer (EUREOC): A Collaborative Study of the Biology of Young Onset CRC, Jose Perea, MD, PhD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain

4:50 PM – 5:00 PM

  • In Development: CRAYON: ColoRectal Cancer in Adults at Young ONset: New York City Based Prospective Accrual Study of Young Onset Colorectal Cancer
    • Steven H. Itzkowitz MD, Icahn School of Medicine at Mount Sinai

5:00 PM – 5:10 PM

  • The Beyond CRC Project  
    • Kimmie Ng, MD, MPH, Dana-Farber Cancer Institute

5:10 PM – 5:20 PM

  • The Search for Novel Drivers of Young Onset MSS CRC: An overview of current NIH, CDC and ACS efforts, Thomas K. Weber, MD, FACS, Northwell Health

5:20 PM – 5:30 PM

  • Report back from Denver EAO CRC Research Meeting, Heather Hampel, The Ohio State University Comprehensive Cancer Center

5:30 PM – 5:45 PM

  • Discussion and “Next Steps”

5:45 PM – 6:45 PM

  • Poster Session and Reception

FRIDAY, MAY 3, 2019

8:00 AM – 9:00 AM REGISTRATION AND BREAKFAST WITH THE DOCTORS (Krista Nelson and Karen Fasciano)

9:00 AM – 9:05 AM WELCOME BACK!

Course Co-Director Wasif M. Saif, MD, MBBS, Northwell Health Cancer Institute

9:00 AM – 9:05 AM HOUSEKEEPING

Course Co-Director Susan Peterson, PhD, MPH, The University of Texas MD Anderson Cancer Center

9:05 AM – 10:05 AM

SESSION VI: PALLIATIVE CARE: WHY EARLY IS BEST. (INCLUDING GUIDANCE, SUPPORT AND RESOURCES TO PATIENTS AND CAREGIVERS DURING THEIR TREATMENT JOURNEY/CONTINUUM OF CARE.  (ADDRESSING GAP 5)

James T. D’Olimpio, MD, FACP, FAAHPM North Shore University Hospital

Sarah Debord, Colon Cancer Coalition

Andy Esch, MD, MBA, Palliative Care and Survivorship of Western New York

Karen Fasciano, PsyD, Dana-Farber Cancer Institute

Susan Pfau,

Krista Nelson, LCSW OSW-C BCD FAOSW,

10:05 AM – 10:25 AM

SESSION VI EPIGENETICS AND ITS FUTURE ROLE IN THE DIAGNOSIS AND TREATMENT OF INDIVIDUALS MORE SPECIFICALLY AND ACCURATELY

  1. Richard Boland, MD, AGAF, UC San Diego

10:25 AM – 10:45 AM

  • Networking, Coffee, Poster Viewing Break

10:45 AM – 11:20 PM

STRATEGIC PLANNING SESSION (BREAKOUT GROUPS ACCORDING TO GAP)

  1. Data, accurate, regular to measurement of key metrics
  2. Family History Ascertainment
  3. Earliest Possible Stage Diagnosis
  4. Development of centers of excellence dedicated to the treatment of EAO CRC patients and caregivers
  5. Research into the causes of early onset colorectal cancers

11:20 AM – 11:45 PM

REPORT BACK FROM STRATEGIC ACTION PLAN BREAKOUT GROUPS

THE EAOCRC PLEDGE

11:45 PM – 12:15 PM

ABSTRACT POSTER SESSION AWARDS

CLOSING REMARKS

INVITED FACULTY

This year the Summit will feature presentations from EAO-CRC survivors, caregivers clinicians from the nation’s leading cancer centers, and representatives of CRC advocacy organizations including 
American Cancer Society
Association of Oncology Social Work
The Cancer Institute at NYU Langone
Chicago Gastro LLC.
Cold Spring Harbor Laboratories
Columbia University
Colorectal Cancer Alliance
Colon Cancer Coalition
Colon Cancer Prevention Project
Dana-Farber Cancer Institute
Duke Cancer Center
Harvard Cancer Institute
Dartmouth Geisel School of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
European Orgnisation for Research and Treatment of Cancer (EOCRT)
Feinstein Institute for Medical Research
European Organization for Research and Treatment of Cancer
Fox Chase Cancer Center
Fundacion Jimenez Diaz University Hospital
Georgia State University
Harvard Medical School
Harvard T.H. Chan School of Public Health
Institute for Biomedical Sciences
Icahn School of Medicine at Mt. Sinai Hospital
Indiana University School of Medicine
Jackson Laboratory for Genomic Medicine
Kaiser Permanente
Laura and Isaac Perlmutter Cancer Center
MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
The Kenneth Offit Lab
Memorial Sloan Kettering Cancer Center
Michael’s Mission
Midwest Gastroenterology Associates
Mt. Sinai Medical Center
National Institutes of Health (NIH)
National Colorectal Cancer Roundtable (NCCRT)
the Never Too Young Coalition
New York Presbyterian/Herbert Irving Comprehensive Cancer Center
New York Citywide Colon Cancer Control Coalition
New York University School of Medicine
North Shore University Hospital
Northwell Health
Northwell Health Cancer Institute
The Ohio State University Comprehensive Cancer Center
Palliative Care and Survivorship of Western New York
Ranbam Health Care Campus
Regenstrief Institute, Inc.
Spectrum Health Medical Group
Tufts University Medical Center
Tulane University School of Medicine
University of Chicago Medicine Comer Children’s Hospital, University of Colorado School of Medicine
UT Southwestern Medical Center
UCSD School of Medicine – San Diego
University of Michigan Rogel Cancer Center,University of Missouri School of Medicine
Washington University School of Medicine
World Health Organization
Yale New Haven Hospital.
Dennis J. Ahnen MD AGAF FACGUniversity of Colorado School of Medicine
Andrew Albert, MD, MPH
Chicago Gastro, LLC
Richard Barakat, MD
Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Irit Ben-Aharon, M, PhD
Ranbam Health Care Campus, European Organisation for Research and Treatment of Cancer (EOCRT)
Semir Beyaz, PhD
Cold Spring Harbor Laboratories
Chelsea Boet, MD
Spectrum health Medical Group
C. Richard Boland MD AGAFUCSD School of Medicine, San Diego
Anne CarlsonColon Cancer Coalition
Yin Cao, MPH, ScD, MPH
Washington University School of Medicine
Andrew Cercek, MD
Memorial Sloan Kettering Cancer Center
Zana Correa, NP
Memorial Sloan Kettering Cancer Center
James T. D’Olimpio, MD, FACP, FAAHPM
North Shore University Hospital
Sarah DebordColon Cancer Coalition
Emily Edelman, MS, CGCThe Jackson Laboratory
Cathy Eng, MD, FACP, FASCO
The University of Texas MD Anderson Cancer Center
Andrew W. Eshe, MD, MBA
Center to Advance Palliative Care
Greg Feero, MD
National Human Genome Research Institute
Heather Hampel MS LGCThe Ohio State University Comprehensive Cancer Center
Richard Hayes, DDS, PhD, MPH
The Cancer Insitute at NYU Langone

Stacy Hurt, MHA, MBAColon Cancer Coalition
Steven H. Itzkowitz, MD
Icahn School of Medicine at Mount Sinai
Whitney Jones MDMidwest Gastroenterology Associates, Colon Cancer Prevention Project

Jordan Karlitz, MD, FACG
Tulane University School of Medicine
Noah Kauff, MD
Duke Cancer Center
Maureen Killackey, MDNew York Presbyterian/Herbert Irving Comprehensive Cancer Center
Sayoni Lahiri, MS, CGC
UT Southwestern Medical Center
Caleb LevellNational Colorectal Cancer Roundtable, American Cancer Society
Xavier Llor, MD, PhD
Cancer Genetics and Prevention Program, Yale New Haven Hospital
Jan Lowry, PhD, MPH
Colorado School of Public Health
Jonathan Mitchem, MD
University of Missouri School of Medicine
Christine Louise S. Molmenti PhDFeinstein Institute for Medical Research, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Krista Nelson, LCSW, OSW-C, BCD, FAOSW
Association of Oncology Social Work
Nicole Noyes, MD
Northwell Health
Jose’ Perea MD PhDFundacion Jimenez Diaz University Hospital
Erin Peterson
Colon Cancer Coalition
Susan Peterson PhD, MPH The University of Texas MD Anderson Cancer Center
Wasif Saif, MD
Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Rebecca L. Siegel, MPHAmerican Cancer Society
Zsophia Stadler MDMemorial Sloan Kettering Cancer Center, The Kenneth Offit Lab
Elena Stoffel, MD
University of Michigan Rogel Cancer Center
Thomas K. Weber MD FACSDirector of Surgical Oncology; Northwest Region at Northwell Health
Ronit Yarden, PhD, MHSAColorectal Cancer Alliance
Mathew B. Yurgelun, MD
Dana-Farber Cancer Insitute, Harvard Medical School
Kana Wu, MD, PhD, MPH
Harvard T.H. Chan School of Public Health, Dana-Farber Cancer Institute, Harvard Medical School

SPONSORS

SPONSORSHIP OPPORTUNITIES

The sponsors of the EAO-CRC Summit make it possible for us to build public awareness of colorectal cancer (CRC) including hereditary colorectal cancer and the importance of timely screening and prevention.  Their support also allows us to help sponsor prevention programs in New York City including screening efforts for the uninsured and innovative translational research projects focused on early age onset of colorectal cancer.

As a sponsor of the Summit you have the opportunity to reach thousands who join us each year to raise awareness of this deadly and yet preventable disease.

If you are interested in joining our community of Sponsors, please contact Sandra Vassos at 914.305.6674.

CME INFORMATION

Accreditation:  This live activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education.

Credit Designation:  To be determined

Disclosure Policy:  The Colon Cancer Foundation adheres to the ACCME’s Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others, are required to disclose all relevant financial relationships with commercial interests. All relevant conflicts of interest will be resolved prior to the commencement of the activity.

ABSTRACT

Deadline for submission 

The EAO-CRC Program Planning Committee invites attendees to submit abstracts for a poster presentation at the sixth annual meeting on April 22 – 23, 2019.  Abstracts may describe research or programs, and may have been presented elsewhere.

ABSTRACT SUBMISSION GUIDELINES

Abstracts should be submitted as an MS Word document to the following email address:  abstracts@coloncancerfoundation.org. Abstracts should include a title, and name(s) of all author(s) and their institution or organization affiliation.  The name of the presenting author should be underlined.  The body of the abstract should not exceed 350 words.  See below for guidelines specific to the body of research and program abstracts.

Research abstracts.  Abstracts describing scientific research on early age onset colorectal cancer should organize the content using the following subheadings:  Background, Methods, Results, and Conclusions. One data table is permitted per abstract. Illustrations and figures are not permitted. Define all abbreviations. Include the abstract title, full names and institutional affiliations of all authors, and email address of the corresponding author at the top of the abstract. Underline the name of the presenting author. Abstracts must not contain copyrighted material unless permission has been obtained by the author. Indicate at the bottom of the page if the abstract has been presented elsewhere and at what meeting. Submitted abstracts not meeting the above specifications will be returned. Any and all relevant conflicts of interest need to be noted at the bottom of the abstract.

Any questions regarding abstract submission should be directed to abstracts@coloncancerfoundation.org

Program abstracts. Abstracts describing programs focused on any aspect of early age onset colorectal cancer should organize the content using the following subheadings:  Program Objectives, Audience, Program Description, Future Directions.  One table is permitted per abstract.  Illustrations and figures are not permitted. Define all abbreviations. Include the abstract title, full names and institutional affiliations of all authors, and email address of the corresponding author at the top of the abstract. Underline the name of the presenting author. Abstracts must not contain copyrighted material unless permission has been obtained by the author. Indicate at the bottom of the page if the abstract has been presented elsewhere and at what meeting. Submitted abstracts not meeting the above specifications will be returned. Any and all relevant conflicts of interest need to be noted at the bottom of the abstract.

Any questions regarding abstract submission should be directed to abstracts@coloncancerfoundation.org

POSTER PRESENTATION SESSIONS

Poster presentations will provide an opportunity for interchange of ideas between the presenter and EAO CRC Summit attendees in his/her study. The poster should be outlined so the research can be understood without an oral explanation as a poster may also be viewed when the author is not present.

Poster location to be determined. Posters will be easily accessible and available for viewing for the duration of the EAO CRC Summit including a reception to be held on the evening of May 2.

Set-Up: Will take place on Wednesday, April 22 time TBFD. Each poster will be assigned a sequential number. Locate your assigned poster board and mount your poster within the time noted on the instructions received once accepted. Pushpins will be provided in the area by the Moderators.

Format of poster is LANDSCAPE (horizontal).

Regular Poster Size Limitations: TBD

Photos, Charts, and Graphs: Charts, drawings, and illustrations should be similar to those you would use in making PowerPoint slides. If photographs are used, please have them processed with a matte or dull finish.

Contact Information: Please clearly print 1 email address on your poster for attendees to refer to should they have any questions or comments at a time when you are not standing with your poster. If you do not wish to print your own email address, please list another email address for an appropriate contact person for your abstract.

Poster Material: The poster can either be made on 1 sheet (rollup) or in several small sections. Do NOT mount illustrations on heavy cardboard because they may be difficult to keep in position on the poster board.

Take-Down: Will take place on Thursday, April 23, 7:30 PM. Please disassemble your posted materials at the end of the EAO CRC Summit. Any materials left on the poster board at the end of the session will be removed and disposed of.

AWARDS AND JUDGING

As part of the abstract review process the poster review committee will identify the top ranking abstracts. The top three abstracts will recognized during the EAO CRC Summit poster session. Awardees will also be recognized during the closing remarks and award ceremony. EAO CRC Summit attendees will also have the opportunity to review posters and vote for the People’s Choice Award.

LIBRARY

CCF Articles

Global Patterns and Trends in Colorectal Cancer
Incidence in Young Adults

EAO CRC Abstracts

The Fifth Annual
EAO-CRC Summit
(2019)

Abstracts

EAO CRC 2019 Agenda

The Fifth Annual
EAO-CRC Summit
(2019)

Agenda

EAO CRC 2019 Video

How Nurses Can Support Physicians
in Identifying Colorectal Cancer Risk
(2019)

Videos

EAO CRC 2019 Video

Be Alert to the Symptoms
of Colorectal Cancer
(2019)

Videos

EAO CRC 2019 Video

The Fifth Annual
EAO-CRC Summit
(2019)

Videos

EAO CRC 2019 Photo Gallery

The Fifth Annual
EAO-CRC Summit
(2019)

Photo Gallery

EAO CRC 2019 Event Slides

The Fifth Annual
EAO-CRC Summit
(2019)
Session i Slides

EAO CRC 2019 Event Slides

The Fifth Annual
EAO-CRC Summit
(2019)
Session ii Slides

EAO CRC 2019 Event Slides

The Fifth Annual
EAO-CRC Summit
(2019)
Session iii Slides

EAO CRC 2019 Event Slides

The Fifth Annual
EAO-CRC Summit
(2019)
Session iv Slides

EAO CRC 2019 Event Slides

The Fifth Annual
EAO-CRC Summit
(2019)
Session v (part one) Slides

EAO CRC 2019 Event Slides

The Fifth Annual
EAO-CRC Summit
(2019)
Session v (part two) Slides

EAO CRC 2019 Event Slides

The Fifth Annual
EAO-CRC Summit
(2019)
Session vi Slides

EAO CRC Archives

The Fourth Annual
EAO-CRC Summit
(2018)

EAO CRC Archives

The Third Annual
EAO-CRC Summit
(2017)

Optimizing Outcomes For EAO-CRC

EAO CRC Archives

The Third Annual
EAO-CRC Summit
(2017)

Finding The Ideal State Of Wellness

EAO CRC Archives

The Third Annual
EAO-CRC Summit
(2017)

Navigating The Survivorship Landscape

EAO CRC Archives

The Second Annual
EAO-CRC Summit
(2016)

EAO CRC Archives

The First Annual
EAO-CRC Summit
(2015)

CCF Articles

(via New York Times)

CCF Articles

(via New York Times)